Subependymal giant cell astrocytoma historical perspective
|
Subependymal giant cell astrocytoma Microchapters |
|
Differentiating Subependymal Giant Cell Astrocytoma from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Subependymal giant cell astrocytoma historical perspective On the Web |
|
American Roentgen Ray Society Images of Subependymal giant cell astrocytoma historical perspective |
|
FDA on Subependymal giant cell astrocytoma historical perspective |
|
CDC on Subependymal giant cell astrocytoma historical perspective |
|
Subependymal giant cell astrocytoma historical perspective in the news |
|
Blogs on Subependymal giant cell astrocytoma historical perspective |
|
Risk calculators and risk factors for Subependymal giant cell astrocytoma historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2], Ifeoma Odukwe, M.D. [3]
Overview
Subependymal giant cell astrocytoma was described as a lesion located in the caudothalamic groove having a size of >1 cm in any direction or a subependymal lesion that has shown serial growth on consecutive imaging regardless of size and location.
Historical Perspective
- In 2012, experts at the International Tuberous Sclerosis Complex Consensus Conference described subependymal giant cell atroctyoma as a lesion located in the caudothalamic groove having a size of >1 cm in any direction or a subependymal lesion that has shown serial growth on consecutive imaging regardless of size and location.[1]
References
- ↑ Jansen AC, Belousova E, Benedik MP, Carter T, Cottin V, Curatolo P; et al. (2019). "Newly Diagnosed and Growing Subependymal Giant Cell Astrocytoma in Adults With Tuberous Sclerosis Complex: Results From the International TOSCA Study". Front Neurol. 10: 821. doi:10.3389/fneur.2019.00821. PMC 6688052 Check
|pmc=value (help). PMID 31428037.